EN
HI
Summary
As of 14 Sep, 2026, Fredun Pharmaceuticals stock price is ₹1412.2. During the trading session, the stock has moved between an intraday low of ₹1400.00 and an intraday high of ₹1450.00. Over the last 52 weeks, Fredun Pharmaceuticals has traded between ₹1320.10 and ₹1590.00.
The stock has recorded a trading volume of 25,210 shares,. Its Average Traded Price (ATP) is ₹1415.97, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹1412.20.
Fredun Pharmaceuticals has an upper circuit limit of ₹1553.40 and a lower circuit limit of ₹1271.00. The total value traded stands at ₹3.57 CR, and the delivery percentage for the day is 49.45%.
The stock is currently traded with a market lot size of 1. Fredun Pharmaceuticals also offers a dividend yield of 0.02%.
Fredun Pharmaceuticals Share Price Chart
Fredun Pharmaceuticals Share Key Metrics
Volume
25210.00
Market Cap
2335.51 CR
LTQ@LTP
3@1412.20
ATP
1415.97
Var Margin
25.59 %
Circuit Range
1271-1553.4
Delivery %
49.45 %
Value
3.57 CR
ASM/GSM
No
Market Lot
1
Fredun Pharmaceuticals Fundamentals
P/E Ratio
53.35
P/B Ratio
7.97
Div. Yield
0.02
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Fredun Pharmaceuticals Resistance and Support
Pivot 1420.73
Resistance
First Resistance
1441.46
Second Resistance
1470.73
Third Resistance
1491.46
Support
First Support
1391.46
Second Support
1370.73
Third Support
1341.46
Fredun Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 1450 | 1412.19 | -3.35% | 1450 | 1400 |
| Thu Sep 10 2026 | 1460 | 1461.19 | 1.53% | 1493 | 1418.19 |
| Wed Sep 09 2026 | 1369.3 | 1439.19 | 6.07% | 1449 | 1348 |
Fredun Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-25 | Preferential Issue of shares & Others |
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-26 | Quarterly Results |
| 2024-10-03 | Others |
| 2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fredun Pharmaceuticals acquired pet wellness brand Furlicks, entering India's high-growth pet wellness market. This strategic move leverages existing manufacturing capabilities and includes plans to launch 44 new SKUs.
Sep 08 2026 11:58:17
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fredun Pharmaceuticals has launched PAWTALKS, a new digital platform dedicated to pet and animal healthcare. This initiative aims to foster knowledge sharing and build a more informed pet care ecosystem by connecting veterinary experts, pet parents, and industry leaders.
Sep 04 2026 09:42:00
Fredun Pharmaceuticals Management
| Name | Position |
|---|---|
| Daisy Dsouza | Non Executive Independent Director |
| Sonal Desai | Non Executive Independent Director |
Fredun Pharmaceuticals Similar Stocks
Panacea Biotec Ltd.
397.65
0.00 (0.00%)
Indoco Remedies Ltd.
263.02
0.00 (0.00%)
Shukra Pharmaceuticals Ltd.
53.94
0.00 (0.00%)
Beta Drugs Ltd.
2118.50
0.00 (0.00%)
Windlas Biotech Ltd.
1129.25
0.00 (0.00%)
Sai Parenteral's Ltd.
523.35
0.00 (0.00%)
Venus Remedies Ltd.
1616.30
0.00 (0.00%)
Hester Biosciences Ltd.
2264.90
0.00 (0.00%)
Syncom Formulations (India) Ltd.
19.46
0.00 (0.00%)
Krsnaa Diagnostics Ltd.
550.05
0.00 (0.00%)
Fredun Pharmaceuticals FAQs
The Buying Price of Fredun Pharmaceuticals share is 1412.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fredun Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fredun Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fredun Pharmaceuticals shares is 53.35. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fredun Pharmaceuticals shares is 7.97. Useful to assess the stock's value relative to its book value.
To assess Fredun Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fredun Pharmaceuticals is 2335.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fredun Pharmaceuticals share price is 1590.00 & 1320.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fredun Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in FREDUN
